In 2026, clinical trial teams market uncertainty and identify high-impact areas for AI adoption to remain competitive.

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...

In this article author Sachin Joglekar discusses the transformation of CLI terminals becoming agentic where developers can state goals while the AI agents plan, call tools, iterate, ask for approval ...

Challenges in UK rail electrification highlight the need for a strategic approach to decarbonize transport while ensuring ...

In his doctoral dissertation in Economics at the Jyväskylä University School of Business and Economics, Finland, Joni Heikkinen, who holds a Master ...

Canada revised its medical assistance in dying (MAiD) legislation to extend eligibility to individuals without a reasonably ...

In addition to providing energy, lipids are also essential building blocks of our cell membranes. However, despite their ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The company's direct, contaminant-free graphene deposition method is a manufacturing breakthroughSAN ANTONIO, Jan. 7, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Paragraf ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Nkembuh, N. (2026) Symbiotic Communication Systems: Examining the Co-Evolution of Human-AI Communication Patterns in the ...